Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Desamparados Roda Perez

Desamparados Roda Perez
Country

Spain

Address
Department of Medical Oncology
University Hospital
Valencia

Desamparados Roda Perez’s career in translational oncology has been associated mainly with her work in the Phase I Trials Unit and in collaboration in the development of new drugs, especially during the last year, during the beginning of her formative period in basic research.

Her training in clinical research is aimed at conducting phase I clinical trials in the Phase I Cancer Unit within the Department of Haematology and Medical Oncology directed by Prof. Andrés Cervantes. In January 2009, she joined the First in Human Unit and since then she has participated actively in all phases of the biologically most relevant questions in phase I studies: individualised therapy for each patient according to molecular selection; biomarkers identification and study of each pathway; and pharmacodynamic and pharmacokinetic analysis for each new drug.

She has contributed to the development of phase I and II trials with novel therapeutic inhibitors of key signalling pathways deregulated in cancer, including the IGFR/PI3K/AKT pathway and the MAP kinase pathway. In addition the group is working to develop treatments to overcome resistance to anti-EGFR therapies.

In January 2011, she received a Río-Hortega grant awarded by the Carlos III Health Institute. This is a three-year grant for training in basic and clinical research. Her training in cellular and molecular biology is carried out in the laboratory of Prof. Juan R. Viña at the Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Valencia, where she is involved in a project on colorectal cancer cell lines concerning resistance to anti-EGFR therapies mediated by K-Ras oncogene mutation.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings